Overview
Status
Active
Registry date
2015-08-11
Share capital
5,000.00 PLN
Registered address
ul. Żwirki I Wigury 37A, 43-190 Mikołów, Poland
Electronic delivery address
AE:PL-71406-16406-DSFBC-32
Financials
Revenue history (in k)
Financial insight
- The statement flags a going concern risk.
Filing timeliness
Financial statements were filed on time, on average 173 days early.
- 202523/01/2026
- 202411/02/2025
- 202324/01/2024
- 202213/03/2023
- 202120/01/2022
- 202018/02/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 3.08kMedianUSD 344.81kAverageUSD 7.16m
Net profit
This companyUSD -9.39kMedianUSD 4.90kAverageUSD 706.58k
Operating costs
This companyUSD 12.47kMedianUSD 396.72kAverageUSD 6.21m
Assets
This companyUSD 66.29kMedianUSD 356.06kAverageUSD 7.10m
Industry
Trademarks
Contract Pharma holds 4 active trademarks registered with the Polish Patent Office. The first mark was filed in 2020.
| Mark | Protected until | |
|---|---|---|
| Contract Pharma | Nov 26, 2035 | |
| REVELLIE(word) | Feb 7, 2031 | |
| drop of beauty(word) | Feb 7, 2031 | |
| berberine slim COMPLEX | Nov 24, 2030 |
Authorized Representatives
Marek Sebastian Gołaszczyk – President of the Management Board
Paweł Szczepan Klita – Attorney-in-fact
Manner of representation
Each member of the management board is authorised to make declarations of will on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Ewelina Anna Gołaszczykage 44 | 30 | $405.19 | 30% |
Paweł Szczepan Klitaage 53 | 33 | $445.71 | 33% |
Piotr Henryk Małeckiage 38 | 33 | $445.71 | 33% |
Others | 4 | $54.02 | 4% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2015-08-26.
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Oct 22, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $3,556$3,556 | Prezes Banku Gospodarstwa Krajowego |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Laboratoria Naturysp. z o.o. | $13,931,403.39 | laboratorianatury.pl | ||
| Norsa Pharmasp. z o.o. | $9,111,390.60 | norsapharma.eu | ||
| Yangosp. z o.o. | $8,214,312.60 | yango.pl | ||
| OnesanoS.A. | $3,063,535.91 | onesano.pl | ||
| Iodica Worldsp. z o.o. | $1,668,750.20 | iodica.pl | ||
| Instytut Urządzeń Ekstrakcyjnychsp. z o.o. | $243,885.18 | sfe.com.pl | ||
| Betterme.Biosp. z o.o. | $55,901.95 | betterme.bio | ||
| Moodarysp. z o.o. | $34,640.14 | ladujemy.pl | ||
| TRZY Wymiarysp. z o.o. | $3,985.66 | agencja3.pl | ||
| ALV Labssp. z o.o. | – | alevita.pl |
Change history
| Date | Event | |
|---|---|---|
| 2025-09-19 | Address change (Ul. Pszowska 43e, 44-300, Wodzisław Śląski → Ul. Żwirki I Wigury 37a, 43-190, Mikołów) | |
| 2025-09-19 | Name change (Sveden Care → Contract Pharma) | |
| 2025-09-19 | PKD change (Added: 8 codes) | |
| 2021-02-04 | Address change (Ul. Pszowska 43, 44-300, Wodzisław Śląski → Ul. Pszowska 43e, 44-300, Wodzisław Śląski) | |
| 2015-08-11 | Entered in the register |
FAQ
The main business activity of Contract Pharma focuses on manufacture of food supplements.
The company was registered in the Polish National Court Register (KRS) on August 11, 2015.
The headquarters is located at: ul. Żwirki I Wigury 37A, 43-190 Mikołów.
The management board includes Marek Sebastian Gołaszczyk (President of the Management Board).
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
The company reported a revenue of $3,076 in 2025, which is a decrease of 71.0% compared to 2024.
No, in 2025 the company was not profitable, reporting a net loss of $9,392.
The largest operating cost category falls under external services. This category amounted to $6,684 in 2025, representing 54% of all operating expenses.
Last updated: 2026-04-13
